"ZAI" の関連情報検索結果

Will Zai Lab Limited Depositary Receipt price bounce be sustainable - Inflation Watch & Daily Ove...



Will Zai Lab Limited Depositary Receipt price bounce be sustainable - Inflation Watch & Daily Oversold Bounce Ideas  Newser

Zai Lab's Path to Profitability: Assessing Financial Turnaround and Pipeline Catalysts in H1 2025...



Zai Lab's Path to Profitability: Assessing Financial Turnaround and Pipeline Catalysts in H1 2025  AInvest

Zai Lab Reports Strong Revenue Growth and Reduced Losses in H1 2025 - TipRanks



Zai Lab Reports Strong Revenue Growth and Reduced Losses in H1 2025  TipRanks

Jefferies assumes coverage on Zai Lab stock with Buy rating, $52 price target - Investing.com



Jefferies assumes coverage on Zai Lab stock with Buy rating, $52 price target  Investing.com

L.L. Bean Summer Intern Zai Yang ’27 Stars in Company Ad - Bowdoin College



L.L. Bean Summer Intern Zai Yang ’27 Stars in Company Ad  Bowdoin College

Zai Lab's Loss Narrows in H1 as Revenue Jumps 15% - MarketScreener



Zai Lab's Loss Narrows in H1 as Revenue Jumps 15%  MarketScreener

Zai Lab Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance



Zai Lab Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag  Yahoo Finance

Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint - Clinical Trials Arena



Amgen and Zai Lab’s trial of gastric cancer therapy meets primary endpoint  Clinical Trials Arena

Predicting Zai Lab Limited Depositary Receipt trend using moving averages - Market Risk Summary &...



Predicting Zai Lab Limited Depositary Receipt trend using moving averages - Market Risk Summary & Weekly High Potential Stock Alerts  Newser

Zai Lab Establishes Oncology Scientific Advisory Board - Business Wire



Zai Lab Establishes Oncology Scientific Advisory Board  Business Wire

Missing – Zai Mables, 22 - Chicago Police Department



Missing – Zai Mables, 22  Chicago Police Department

How Stronger Q2 Results and New Oncology Advisory Board at Zai Lab (ZLAB) Have Changed Its Invest...



How Stronger Q2 Results and New Oncology Advisory Board at Zai Lab (ZLAB) Have Changed Its Investment Story  simplywall.st

Here's What Analysts Are Forecasting For Zai Lab Limited (NASDAQ:ZLAB) After Its Second-Quarter R...



Here's What Analysts Are Forecasting For Zai Lab Limited (NASDAQ:ZLAB) After Its Second-Quarter Results  Yahoo Finance

Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device...



Zai Lab Announces China National Medical Products Administration Grants Innovative Medical Device Designation for Tumor Treating Fields for Patients with Pancreatic Cancer  Business Wire

Long term hold vs stop loss in Zai Lab Limited Depositary Receipt - Product Launch & Real-Time Bu...



Long term hold vs stop loss in Zai Lab Limited Depositary Receipt - Product Launch & Real-Time Buy Signal Notifications  Newser

Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook - Yahoo Finance



Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook  Yahoo Finance

What Fibonacci levels say about Zai Lab Limited Depositary Receipt rebound - Trade Performance Su...



What Fibonacci levels say about Zai Lab Limited Depositary Receipt rebound - Trade Performance Summary & Target Return Focused Stock Picks  Newser

Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings - Yahoo Finance



Here's What Key Metrics Tell Us About Zai Lab Limited (ZLAB) Q2 Earnings  Yahoo Finance

Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout - Yahoo ...



Zai Lab Limited (ZLAB): Among Stocks Insiders Sold in April After Trump’s Tariff Rollout  Yahoo Finance

Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment - Yahoo Finance



Zai Lab Ltd (ZLAB) Delivers Positive Results for Potential Gastric Cancer Treatment  Yahoo Finance

Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3 - Fierce Biotech



Amgen's FGFR2b-targeting cancer candidate boosts overall survival in phase 3  Fierce Biotech

DL Zai'Vion Meads has fall visits scheduled - 247Sports



DL Zai'Vion Meads has fall visits scheduled  247Sports

Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August ...



Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025  Business Wire

Beach Buddies: Adopt Zai - Audacy



Beach Buddies: Adopt Zai  Audacy

Zai Lab's Path to Profitability: Analyzing Revenue Growth, Shrinking Losses, and High-Impact Prod...



Zai Lab's Path to Profitability: Analyzing Revenue Growth, Shrinking Losses, and High-Impact Product Launches  AInvest

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conju...



Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer  Yahoo Finance

Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis - Yahoo ...



Zai Lab (ZLAB) Delivers Positive ZL-1503 Trial Results in Treatment of Atopic Dermatitis  Yahoo Finance

BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race - Deadline



BBC Content Job: Zai Bennett Drops Out Of Charlotte Moore Race  Deadline

Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha



Zai Lab Limited Is Well Positioned For Long-Term Growth  Seeking Alpha

Zai Lab Ltd’s Earnings Call Highlights Growth and Profitability Path - TipRanks



Zai Lab Ltd’s Earnings Call Highlights Growth and Profitability Path  TipRanks

Zai Lab ADR Earns Relative Strength Rating Upgrade - Investor's Business Daily



Zai Lab ADR Earns Relative Strength Rating Upgrade  Investor's Business Daily

Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor ...



Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer  Business Wire

Zai Lab Reports Growth and Strategic Progress in Q2 2025 - TipRanks



Zai Lab Reports Growth and Strategic Progress in Q2 2025  TipRanks

Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33% - simplywa...



Revenues Not Telling The Story For Zai Lab Limited (NASDAQ:ZLAB) After Shares Rise 33%  simplywall.st

Zai Lab Ltd (ZLAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Path to Profitabil...



Zai Lab Ltd (ZLAB) Q4 2024 Earnings Call Highlights: Robust Revenue Growth and Path to Profitability  Yahoo Finance

Zai Lab Limited's (NASDAQ:ZLAB) large institutional owners must be happy as stock continues to im...



Zai Lab Limited's (NASDAQ:ZLAB) large institutional owners must be happy as stock continues to impress, up 4.9% over the past week  simplywall.st

Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AAC...



Zai Lab to Present New Data from Internally Developed, Next-Generation Oncology Candidates at AACR 2025 Annual Meeting  BioSpace

2027 DL Zai'Vion Meads to visit Purdue - 247Sports



2027 DL Zai'Vion Meads to visit Purdue  247Sports

Zai Lab's Q2 2025 Financial Results and Strategic Milestones: A Catalyst for Long-Term Shareholde...



Zai Lab's Q2 2025 Financial Results and Strategic Milestones: A Catalyst for Long-Term Shareholder Value  AInvest

Khrystyna Zai performs at event celebrating the Kurt & Marilyn Wallach Holocaust and Jewish Studi...



Khrystyna Zai performs at event celebrating the Kurt & Marilyn Wallach Holocaust and Jewish Studies Building  Florida Atlantic University

Zai Lab and Pfizer to commercialise XACDURO in China - Pharmaceutical Technology



Zai Lab and Pfizer to commercialise XACDURO in China  Pharmaceutical Technology

Ahmed al-Sharaa zai je Majalisar Dinkin Duniya - DW



Ahmed al-Sharaa zai je Majalisar Dinkin Duniya  DW

Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire



Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates  Business Wire

Defect Engineering toward High‐Performance Tin‐Based Perovskite Field‐Effect Transistors - Wiley



Defect Engineering toward High‐Performance Tin‐Based Perovskite Field‐Effect Transistors  Wiley

Zai Lab Ltd Grants Restricted Share Units to Employees - TipRanks



Zai Lab Ltd Grants Restricted Share Units to Employees  TipRanks

Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire



Zai Lab Announces Second Quarter 2025 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts - Yahoo Finance



Zai Lab Limited (ZLAB): Among the Best Breakout Stocks to Buy According to Analysts  Yahoo Finance

Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB) - Seeking Alpha



Zai Lab Limited: Banking On Chinese Pharma Growth (NASDAQ:ZLAB)  Seeking Alpha

Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Ant...



Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual Meeting  Business Wire

Zai Calliste: Company Bound - Dance Australia



Zai Calliste: Company Bound  Dance Australia

Zai Lab Targets $2 Bln In Revenue By 2028 - Nasdaq



Zai Lab Targets $2 Bln In Revenue By 2028  Nasdaq

Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025? - Yahoo Finance



Is Zai Lab Limited (ZLAB) the Best Performing Growth Stock in 2025?  Yahoo Finance

Vertex out-licenses povetacicept to Zai Lab - The Pharma Letter



Vertex out-licenses povetacicept to Zai Lab  The Pharma Letter

Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2...



Zai Lab to Announce First Quarter 2025 Financial Results and Recent Corporate Updates on May 8, 2025  Business Wire

Zai Lab to Review and Publish Interim Financial Results - TipRanks



Zai Lab to Review and Publish Interim Financial Results  TipRanks

Trump zai shirya taro tsakanin Putin da Zelensky - DW



Trump zai shirya taro tsakanin Putin da Zelensky  DW

Bristol Myers partner Zai Lab plots KarXT filing in China after trial win - Fierce Pharma



Bristol Myers partner Zai Lab plots KarXT filing in China after trial win  Fierce Pharma

Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Tr...



Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025  Business Wire

Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conju...



Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer  Business Wire

Zai Bennett unveils BBCS Productions leadership changes - Televisual



Zai Bennett unveils BBCS Productions leadership changes  Televisual

Zai Lab to Announce 2025 Interim Results on August 7 - TipRanks



Zai Lab to Announce 2025 Interim Results on August 7  TipRanks

Cantor Fitzgerald reiterates overweight rating on Zai Lab stock - Investing.com



Cantor Fitzgerald reiterates overweight rating on Zai Lab stock  Investing.com

As DLL3 heats up, early data for Zai Lab's ADC sets up case for differentiation - FirstWord Pharma



As DLL3 heats up, early data for Zai Lab's ADC sets up case for differentiation  FirstWord Pharma

Meet Zai . | Fine art photographer & Cinematographer - SHOUTOUT LA



Meet Zai . | Fine art photographer & Cinematographer  SHOUTOUT LA

Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks - Seeking Alpha



Zai Lab: Still Attractive Despite Higher Costs And Added Trade War Risks  Seeking Alpha

Zai Lab Ltd (ZLAB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Ya...



Zai Lab Ltd (ZLAB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...  Yahoo Finance

Zai Lab presents positive outcomes from KarXT Phase III trial for schizophrenia - Clinical Trials...



Zai Lab presents positive outcomes from KarXT Phase III trial for schizophrenia  Clinical Trials Arena

Zai steps down steps down from general manager role at Tundra Esports, returns to 'free agency' -...



Zai steps down steps down from general manager role at Tundra Esports, returns to 'free agency'  GosuGamers

Meet Fu Zai, China's First Police Corgi With 400,000 Followers And A Nose For Trouble - NDTV



Meet Fu Zai, China's First Police Corgi With 400,000 Followers And A Nose For Trouble  NDTV

Adnan Zai - Crain's Cleveland Business



Adnan Zai  Crain's Cleveland Business

Investors in Zai Lab (NASDAQ:ZLAB) from three years ago are still down 51%, even after 5.7% gain ...



Investors in Zai Lab (NASDAQ:ZLAB) from three years ago are still down 51%, even after 5.7% gain this past week  simplywall.st

Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Anti...



Zai Lab Announces Strategic Partnership with MediLink Therapeutics to Develop a Novel LRRC15 Antibody-Drug Conjugate  Business Wire

Cantor Fitzgerald maintains Overweight on Zai Lab shares - Investing.com



Cantor Fitzgerald maintains Overweight on Zai Lab shares  Investing.com

Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (T...



Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting  Business Wire

Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients ...



Zai Lab Announces Acceptance of Supplemental New Drug Application for Repotrectinib for Patients with NTRK-Positive Solid Tumors  BioSpace

Zai Lab stock soars to 52-week high, hits $39.66 - Investing.com



Zai Lab stock soars to 52-week high, hits $39.66  Investing.com

Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sul...



Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug XACDURO® (Sulbactam-Durlobactam)  BioSpace

Wane gurbi Eze zai buga a Arsenal? - BBC



Wane gurbi Eze zai buga a Arsenal?  BBC

Arrests made in fatal shooting near PCB Waffle House - WTVY



Arrests made in fatal shooting near PCB Waffle House  WTVY

Zai Lab stock price target raised to $75 from $73 at Leerink Partners - Investing.com



Zai Lab stock price target raised to $75 from $73 at Leerink Partners  Investing.com

Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB) - Seek...



Zai Lab: Innovative Pharma Set For Strong Year Of Business (And Share Price) Growth (ZLAB)  Seeking Alpha

As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab a...



As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact  Fierce Pharma

This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test - Investor's Business Daily



This Biotech Leader Just Hit A 16-Month High On An 'Impressive' Test  Investor's Business Daily

Zai Lab gets FDA fast track status for lung cancer treatment - Seeking Alpha



Zai Lab gets FDA fast track status for lung cancer treatment  Seeking Alpha

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Main...



Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore  Business Wire

Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire



Zai Lab Announces Third Quarter 2024 Financial Results and Recent Corporate Updates  Business Wire

Zai Lab Limited Announces Relocation of PRC Headquarters - TipRanks



Zai Lab Limited Announces Relocation of PRC Headquarters  TipRanks

Zai Lab Launches $200 Million Public Offering - Nasdaq



Zai Lab Launches $200 Million Public Offering  Nasdaq

The Four-Eyes Zai Fried Hokkien Mee: Hyped-up old-school wet HKM that’s only open for 4 hours - Y...



The Four-Eyes Zai Fried Hokkien Mee: Hyped-up old-school wet HKM that’s only open for 4 hours  Yahoo Lifestyle Singapore

Amgen, Zai Lab succeed in gastric cancer study (AMGN:NASDAQ) - Seeking Alpha



Amgen, Zai Lab succeed in gastric cancer study (AMGN:NASDAQ)  Seeking Alpha

Revolutionary Cancer Breakthrough: Zai Lab's Dual-Attack Strategy Against Hard-to-Treat Tumors - ...



Revolutionary Cancer Breakthrough: Zai Lab's Dual-Attack Strategy Against Hard-to-Treat Tumors  Stock Titan

All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy - Nasdaq



All You Need to Know About Zai Lab Limited (ZLAB) Rating Upgrade to Buy  Nasdaq

How the Zai farming technique is transforming soil fertility in North Cameroon - Mongabay



How the Zai farming technique is transforming soil fertility in North Cameroon  Mongabay

Zai Lab Announces Participation in Investor Conferences in March 2025 - BioSpace



Zai Lab Announces Participation in Investor Conferences in March 2025  BioSpace

Zai Lab announces acceptance of BLA for TIVDAK in cervical cancer - Yahoo Finance



Zai Lab announces acceptance of BLA for TIVDAK in cervical cancer  Yahoo Finance

Zhu Zhu Zai: Ex-private dining chef sells lu rou fan & braised pork pizza from $3.80 - Yahoo Life...



Zhu Zhu Zai: Ex-private dining chef sells lu rou fan & braised pork pizza from $3.80  Yahoo Lifestyle Singapore

Zai Lab Ltd Grants Share Options and Units Under 2024 Equity Plan - TipRanks



Zai Lab Ltd Grants Share Options and Units Under 2024 Equity Plan  TipRanks

Babu wani mahaluki da zai hanamu gudanar taron PDP na kasa - Bala Muhammed - BBC



Babu wani mahaluki da zai hanamu gudanar taron PDP na kasa - Bala Muhammed  BBC

Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tu...



Zai Lab and Novocure Announce Positive Topline Results from Phase 3 PANOVA-3 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer  Business Wire

Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say - Nasdaq



Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say  Nasdaq